High-dose testosterone is associated with atherosclerosis in postmenopausal women

Maturitas

Volumn 56, Issue 2, 2007, Pages 153-160

  Hak, A Elisabeth ^a   Westendorp, Iris C D ^a   Pols, Huibert A P ^a   Hofman, Albert ^a   Witteman, Jacqueline C M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Androgen replacement therapy; Atherosclerosis; Postmenopausal women

Indexed keywords

ESTRADIOL; TESTOSTERONE ESTER;

ABDOMINAL AORTA; ADULT; AGED; ALCOHOL CONSUMPTION; AORTA ATHEROSCLEROSIS; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG MEGADOSE; FEMALE; HORMONE SUBSTITUTION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MENOPAUSE; POSTMENOPAUSE; SELF REPORT; SMOKING; SYSTOLIC BLOOD PRESSURE;

AGED; AORTA, ABDOMINAL; ATHEROSCLEROSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; ESTROGEN REPLACEMENT THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAMUSCULAR; MIDDLE AGED; POSTMENOPAUSE; TESTOSTERONE;

EID: 33846098244     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2006.07.004     Document Type: Article

References (37)

1. Khosla S., Melton III L.J., Atkinson E.J., O'Fallon W.M., Klee G.G., and Riggs B.L. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab 83 7 (1998) 2266-2274
2. McCoy N.L., and Davidson J.M. A longitudinal study of the effects of menopause on sexuality. Maturitas 7 3 (1985) 203-210
3. Davis S.R., and Burger H.G. Clinical review 82: androgens and the postmenopausal woman. J Clin Endocrinol Metab 81 8 (1996) 2759-2763
4. Shifren J.L., Braunstein G.D., Simon J.A., et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 343 10 (2000) 682-688
5. Erdtsieck R.J., Pols H.A., van Kuijk C., et al. Course of bone mass during and after hormonal replacement therapy with and without addition of nandrolone decanoate. J Bone Miner Res 9 2 (1994) 277-283
6. Watts N.B., Notelovitz M., Timmons M.C., Addison W.A., Wiita B., and Downey L.J. Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopause. Obstet Gynecol 85 4 (1995) 529-537
7. Davis S. Androgen replacement in women: a commentary. J Clin Endocrinol Metab 84 6 (1999) 1886-1891
8. van Hemert A.M., Vandenbroucke J.P., Hofman A., and Valkenburg H.A. Metacarpal bone loss in middle-aged women: "horse racing" in a 9-year population based follow-up study. J Clin Epidemiol 43 6 (1990) 579-588
9. Witteman J.C., Grobbee D.E., Valkenburg H.A., et al. J-shaped relation between change in diastolic blood pressure and progression of aortic atherosclerosis. Lancet 343 8896 (1994) 504-507
10. Witteman J.C., Grobbee D.E., Valkenburg H.A., van Hemert A.M., Stijnen T., and Hofman A. Cigarette smoking and the development and progression of aortic atherosclerosis. A 9-year population-based follow-up study in women. Circulation 88 5 Pt 1 (1993) 2156-2162
11. Hyman J.B., and Epstein F.H. A study of the correlation between roentgenographic and postmortem calcifications of the aorta. Am Heart J 48 (1954) 540-543
12. Orr D.P., Myerowitz R.L., Herbert D.L., and Friday P. Correlation of radiographic and histologic findings in arterial calcification. Invest Radiol 13 2 (1978) 110-114
13. Bots M.L., Witteman J.C., and Grobbee D.E. Carotid intima-media wall thickness in elderly women with and without atherosclerosis of the abdominal aorta. Atherosclerosis 102 1 (1993) 99-105
14. Witteman J.C., Kannel W.B., Wolf P.A., et al. Aortic calcified plaques and cardiovascular disease (the Framingham Study). Am J Cardiol 66 15 (1990) 1060-1064
15. Witteman J.C., Kok F.J., van Saase J.L., and Valkenburg H.A. Aortic calcification as a predictor of cardiovascular mortality. Lancet 2 8516 (1986) 1120-1122
16. Matthews K.A., Kuller L.H., Wing R.R., Meilahn E.N., and Plantinga P. Prior to use of estrogen replacement therapy, are users healthier than nonusers?. Am J Epidemiol 143 10 (1996) 971-978
17. Stampfer M.J., and Colditz G.A. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 20 1 (1991) 47-63
18. Grady D., Rubin S.M., Petitti D.B., et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 117 12 (1992) 1016-1037
19. Barrett-Connor E., and Grady D. Hormone replacement therapy, heart disease, and other considerations. Annu Rev Public Health 19 (1998) 55-72
20. Polderman K.H., Gooren L.J., Asscheman H., Bakker A., and Heine R.J. Induction of insulin resistance by androgens and estrogens. J Clin Endocrinol Metab 79 1 (1994) 265-271
21. Bruck B., Brehme U., Gugel N., et al. Gender-specific differences in the effects of testosterone and estrogen on the development of atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol 17 10 (1997) 2192-2199
22. Goodman M.T., Nomura A.M., Wilkens L.R., and Kolonel L.N. Agreement between interview information and physician records on history of menopausal estrogen use. Am J Epidemiol 131 5 (1990) 815-825
23. Judd H.L. Hormonal dynamics associated with the menopause. Clin Obstet Gynecol 19 4 (1976) 775-788
24. Amarenco P., Cohen A., Tzourio C., et al. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med 331 22 (1994) 1474-1479
25. Wild R.A., Grubb B., Hartz A., Van Nort J.J., Bachman W., and Bartholomew M. Clinical signs of androgen excess as risk factors for coronary artery disease. Fertil Steril 54 2 (1990) 255-259
26. Talbott E., Guzick D., Clerici A., et al. Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb Vasc Biol 15 7 (1995) 821-826
27. Talbott E.O., Guzick D.S., Sutton-Tyrrell K., et al. Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women. Arterioscler Thromb Vasc Biol 20 11 (2000) 2414-2421
28. Haffner S.M., Newcomb P.A., Marcus P.M., Klein B.E., and Klein R. Relation of sex hormones and dehydroepiandrosterone sulfate (DHEA-SO4) to cardiovascular risk factors in postmenopausal women. Am J Epidemiol 142 9 (1995) 925-934
29. Phillips G.B., Pinkernell B.H., and Jing T.Y. Relationship between serum sex hormones and coronary artery disease in postmenopausal women. Arterioscler Thromb Vasc Biol 17 4 (1997) 695-701
30. Barrett-Connor E., and Goodman-Gruen D. Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women. BMJ 311 7014 (1995) 1193-1196
31. Bernini G.P., Sgro M., Moretti A., et al. Endogenous androgens and carotid intimal-medial thickness in women. J Clin Endocrinol Metab 84 6 (1999) 2008-2012
32. Adams M.R., Williams J.K., and Kaplan J.R. Effects of androgens on coronary artery atherosclerosis and atherosclerosis-related impairment of vascular responsiveness. Arterioscler Thromb Vasc Biol 15 5 (1995) 562-570
33. Bardin C.W., Swerdloff R.S., and Santen R.J. Androgens: risks and benefits. J Clin Endocrinol Metab 73 1 (1991) 4-7
34. Barrett-Connor E., Young R., Notelovitz M., et al. A two-year, double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women. Effects on bone mineral density, symptoms and lipid profiles. J Reprod Med 44 12 (1999) 1012-1020
35. Castelo-Branco C., Vicente J.J., Figueras F., et al. Comparative effects of estrogens plus androgens and tibolone on bone, lipid pattern and sexuality in postmenopausal women. Maturitas 34 2 (2000) 161-168
36. Lapidus L., Bengtsson C., Larsson B., Pennert K., Rybo E., and Sjostrom L. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J (Clin Res Ed) 289 6454 (1984) 1257-1261
37. Rexrode K.M., Carey V.J., Hennekens C.H., et al. Abdominal adiposity and coronary heart disease in women. JAMA 280 21 (1998) 1843-1848